Respira to Submit Drug Application for Inhalable NRT

    The technology represents the world’s first inhalable nicotine-replacement therapy, according to its manufacturer.


    More news this week


    In Print


    Great Expectations

    Brexit allows the U.K. to pursue its progressive harm reduction approach.

    Down to the Wire

    Uncertainty lingers as the FDA decides the fate of the remaining marketing applications.

    Fighting the Last War

    A new report urges the World Health Organization to embrace safer nicotine products.

    No Paper Tiger

    SWM has introduced a new gumming technology to protect brands against counterfeiting.

    A Common Language

    MedDRA helps evaluators describe the health effects of tobacco products in consistent terms.

    Uniquely Deadly

    India’s crackdown on smokeless should be complemented by a more coherent THR strategy.

    Back in Business

    Impressions from the recent World Tobacco exhibition in Dubai.

    The Stubborn Squad

    In trying to engineer consumer choices, COP9 delegates persist in their Luddite approach.

    Clouded in Confusion

    Uncertainty persists even as the FDA approves an ENDS product for marketing.

    Tobacco Reporter December 2021

    Tobacco Reporter’s December 2021 issue highlights synthetic nicotine, which has gained popularity among U.S. e-cigarette manufacturers as the Food and Drug Administration buried the vapor business in marketing denial orders. Is synthetic nicotine a legitimate alternative to the naturally derived variety, or does it represent a loophole? Cheryl Olsen and Willie McKinney share their thoughts on the controversy.

    George Gay reflects on the recently concluded ninth Conference of the Parties to the World Health Organization’s Framework Convention on Tobacco Control and Clive Bates describes the two camps in tobacco control—transformers and abolitionists.

    Also in this issue: a look at the Medical Dictionary for Regulatory Activities, which helps evaluators describe the health effects of tobacco products in consistent terms, and a report on India’ notoriously harmful indigenous smokeless tobacco products.


    Clive Bates

    A regular contributor to Tobacco Reporter, Clive Bates is the director of Counterfactual Consulting and the former director of Action on Smoking and Health (U.K.).

    In this section, we present a selection of his articles.



    Fresh Thinking

    The World Health Organization and tobacco policy: a seven-point reform agenda

    The Endgame Revisited

    It is time to confront the fundamental confusion about the public health aims for tobacco and nicotine policy.


    Now available


    Also in TR

    COP9 Coverage

    Our coverage of the ninth Conference of the Parties to the WHO Framework Convention on Tobacco Control

    A Tale of Two COPs

    The striking differences between this month’s UN climate gathering and the FCTC COP9.

    Stepping Up

    Hall Analytical is investing in reduced-risk product analysis to meet growing demand driven.